1. Ferradini, L., Mackenson, A., Genevee, C., Bosq, J., Duvillard, P., Avril, M. and Hercend, T. 1993. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. J. Clin. Invest.91:1183.
2. Mackensen, A., Ferradini, L., Carcelain, G., Triebel, F., Faure, F., Viel, S. and Hercend, T. 1993. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res.53:3569.
3. Akporiaye, E. T., Kudalore, M., Stevenson, A. P., Kraemer, P. M. and Stewart, C. C. 1988. Isolation and reactivity of host effectors associated with the manifestation of concomitant tumor immunity. Cancer Res.48:1153.
4. Akporiaye, E. T. and Kudalore, M. K. 1989. Implantation of a gelatin-sponge as a model for effector recruitment. Cancer Immunol. Immunother.29:199.
5. Kurt, R. A., Park, J. A., Panelli, M. C., Schluter, S. F., Marchalonis, J. J., Carolus, B. and Akporiaye, E. T. 1995. T lymphocytes infiltrating sites of tumor rejection and progression display identical Vβ usage but different cytotoxic activities. J. Immunol.154: 3969.